LifePulse High Frequency Ventilator (HFV)
Bunnell, Inc. · Decision date Jul 25, 2025
What did the FDA approve?
FDA records P850064/S055 as a supplement to PMA P850064, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 25, 2025.
FDA approval order statement
for a change to materials in the Patient Circuit based on their biocompatibility profile. The changes include: a change to circuit tubing material (no change to tubing type or dimensions), change in the anodization process of the heater cup, and replacing the adhesives used with medical grade adhesives.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Anesthesiology
- Decision date
- Jul 25, 2025
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P850064/S055
- Regulatory pathway
- PMA supplement
- Applicant
- Bunnell, Inc.
- Product code
- LSZ
- Decision code
- APPR
- Decision date
- Jul 25, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: VENTILATOR, HIGH FREQUENCY.
- Applicant
- Bunnell, Inc.
- Product code
- LSZ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P850064. Subsequent supplements may change the device or its indications.
FDA decision timeline
P850064 · Original PMA
MODEL 203 LIFE PULSE HIGH FREQUENCY VENTILATOR
P850064/S055 received
Application receipt date recorded by FDA.
P850064/S055 · FDA decision
Real-Time Process
P850064/S058 · Related supplement
LifePulse High Frequency Ventilator (LifePulse HFV) Model 204
P850064/S056 · Related supplement
LifePulse High Frequency Ventilator
Timeline entries are records held by MedtechLedger for P850064. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P850064
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bunnell, Inc. | PMA approval | Jun 30, 1988 | FDA | |
| Bunnell, Inc. | PMA supplement | May 7, 2026 | FDA | |
LifePulse High Frequency VentilatorP850064/S056 | Bunnell, Inc. | PMA supplement | Sep 28, 2026 | FDA |
Explore the linked device profile
Other records with product code LSZ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MODEL 3100 FREQUENCY OSCILLATORY VENTILATORP890057/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Jul 23, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bunnell, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 436 Lawndale Dr., Salt Lake City, UT, 84115
Sources and methodology
- Original FDA record: P850064/S055
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


